• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌启动子全基因组分析的表观遗传学景观。

The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer.

机构信息

Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001, Clermont-Ferrand, France.

INSERM U 1240, IMOST, 58 rue Montalembert-BP184, 63005, Clermont-Ferrand, France.

出版信息

Sci Rep. 2017 Jul 26;7(1):6597. doi: 10.1038/s41598-017-06790-z.

DOI:10.1038/s41598-017-06790-z
PMID:28747748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5529370/
Abstract

Breast cancer is a heterogeneous disease due to its clinico-pathological features and response to therapy. The classification of breast tumors based on their hormone receptor status and pathologic features. Post-translational histone modifications come into prominence for regulation of gene expression in cancer pathogenesis. Here, we analyzed dysregulation of H3K9ac and H3K27me3-enriched subtype-specific genes using ChIP-on-chip assay in breast cancer tumors and matched normal tissue samples. Breast cancer tumors were classified according to St Gallen Consensus 2013. Our results indicated that the promoter regions of genes modified by H3K9ac epi-mark are commonly associated with tumors with HER2-positive and TNBC subtype. H3K27me3-enriched genes were comprised of Luminal A and B1 subtypes. We constructed a network structure to elicit epigenetically regulated genes related with breast cancer progression. The central genes of the network (RUNX1, PAX3, GATA4 and DLX5) were subjected for epigenetically dysregulation in association with different breast cancer subtypes. Our study submits epigenetic mechanisms are crucial to elicit subtype-specific regulation in breast cancer and ChIP-on-chip assay provides a better understanding for breast tumorigenesis and new approaches for prevention and treatment.

摘要

乳腺癌是一种异质性疾病,其临床病理特征和对治疗的反应各不相同。基于激素受体状态和病理特征对乳腺肿瘤进行分类。组蛋白翻译后修饰在癌症发病机制中的基因表达调控中变得尤为重要。在这里,我们使用 ChIP-on-chip 分析了乳腺癌肿瘤和配对的正常组织样本中 H3K9ac 和 H3K27me3 富集的亚类特异性基因的失调。乳腺癌根据 2013 年圣加仑共识进行分类。我们的结果表明,H3K9ac epi 标记修饰的基因启动子区域通常与 HER2 阳性和 TNBC 亚型的肿瘤相关。H3K27me3 富集的基因包括 Luminal A 和 B1 亚型。我们构建了一个网络结构,以阐明与乳腺癌进展相关的受表观遗传调控的基因。该网络的核心基因(RUNX1、PAX3、GATA4 和 DLX5)与不同的乳腺癌亚型相关的表观遗传失调。我们的研究表明,表观遗传机制对于引出乳腺癌的亚型特异性调控至关重要,而 ChIP-on-chip 分析为乳腺癌的发生提供了更好的理解,并为预防和治疗提供了新的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9703/5529370/6543f32cad29/41598_2017_6790_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9703/5529370/0fa66ad00c1a/41598_2017_6790_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9703/5529370/1bc24c27e5e3/41598_2017_6790_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9703/5529370/600ba8038f1a/41598_2017_6790_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9703/5529370/6543f32cad29/41598_2017_6790_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9703/5529370/0fa66ad00c1a/41598_2017_6790_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9703/5529370/1bc24c27e5e3/41598_2017_6790_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9703/5529370/600ba8038f1a/41598_2017_6790_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9703/5529370/6543f32cad29/41598_2017_6790_Fig4_HTML.jpg

相似文献

1
The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer.乳腺癌启动子全基因组分析的表观遗传学景观。
Sci Rep. 2017 Jul 26;7(1):6597. doi: 10.1038/s41598-017-06790-z.
2
H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes.乳腺肿瘤分子亚型中的H3K4乙酰化、H3K9乙酰化和H3K27甲基化
Epigenomics. 2016 Jul;8(7):909-24. doi: 10.2217/epi-2016-0015. Epub 2016 Jul 18.
3
Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.比较表观遗传学分析揭示了乳腺癌亚型中致癌途径激活的不同模式。
Hum Mol Genet. 2014 Oct 15;23(20):5378-93. doi: 10.1093/hmg/ddu256. Epub 2014 May 27.
4
Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.分析 HER2+乳腺癌细胞系中 H3K4me3 和 H3K27me3 双价启动子,发现其随雌激素受体状态的变化而变化,并与基因表达显著相关。
BMC Med Genomics. 2020 Jul 3;13(1):92. doi: 10.1186/s12920-020-00749-2.
5
A novel subtype classification and risk of breast cancer by histone modification profiling.通过组蛋白修饰谱对乳腺癌进行新型亚型分类及风险评估
Breast Cancer Res Treat. 2016 Jun;157(2):267-279. doi: 10.1007/s10549-016-3826-8. Epub 2016 May 13.
6
Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.组蛋白H3赖氨酸4乙酰化和甲基化动态变化定义乳腺癌亚型。
Oncotarget. 2016 Feb 2;7(5):5094-109. doi: 10.18632/oncotarget.6922.
7
Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression.作为前列腺癌进展中表观遗传标记的H3K27me3的全局分析。
BMC Cancer. 2017 Apr 12;17(1):261. doi: 10.1186/s12885-017-3256-y.
8
Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity.乳腺癌细胞中的肿瘤胎儿表观遗传双价性:H3K4和H3K27三甲基化作为表型可塑性的生物标志物
J Cell Physiol. 2016 Nov;231(11):2474-81. doi: 10.1002/jcp.25359. Epub 2016 Mar 10.
9
Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.组合表观遗传调控非编码 RNA 对乳腺癌亚型致癌途径有深远影响。
Brief Bioinform. 2018 Jan 1;19(1):52-64. doi: 10.1093/bib/bbw099.
10
Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.组蛋白标记调控诱导的OCT4过表达在乳腺癌进展中起关键作用。
Gene. 2018 Feb 15;643:35-45. doi: 10.1016/j.gene.2017.11.077. Epub 2017 Dec 1.

引用本文的文献

1
Targeting Triple-Negative Breast Cancer: Resistance Mechanisms and Therapeutic Advancements.靶向三阴性乳腺癌:耐药机制与治疗进展
Cancer Med. 2025 May;14(9):e70803. doi: 10.1002/cam4.70803.
2
Landscape of lncRNAs expressed in Mexican patients with triple‑negative breast cancer.墨西哥三阴性乳腺癌患者中lncRNAs的表达情况
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13528. Epub 2025 Apr 11.
3
Decoding the Epigenome of Breast Cancer.解读乳腺癌的表观基因组。

本文引用的文献

1
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells.RUNX1有助于乳腺癌细胞中的高阶染色质组织和基因调控。
Biochim Biophys Acta. 2016 Nov;1859(11):1389-1397. doi: 10.1016/j.bbagrm.2016.08.003. Epub 2016 Aug 9.
2
H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes.乳腺肿瘤分子亚型中的H3K4乙酰化、H3K9乙酰化和H3K27甲基化
Epigenomics. 2016 Jul;8(7):909-24. doi: 10.2217/epi-2016-0015. Epub 2016 Jul 18.
3
Epigenetic Modifications with DZNep, NaBu and SAHA in Luminal and Mesenchymal-like Breast Cancer Subtype Cells.
Int J Mol Sci. 2025 Mar 13;26(6):2605. doi: 10.3390/ijms26062605.
4
The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancer.PRC2复合物通过表观遗传方式使GATA4沉默,以抑制细胞衰老并促进乳腺癌进展。
Transl Oncol. 2024 Aug;46:102014. doi: 10.1016/j.tranon.2024.102014. Epub 2024 Jun 5.
5
Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response.表观遗传修饰因子在乳腺癌发病机制和治疗反应中的新作用
Cancers (Basel). 2023 Aug 7;15(15):4005. doi: 10.3390/cancers15154005.
6
Imaging-based study demonstrates how the DEK nanoscale distribution differentially correlates with epigenetic marks in a breast cancer model.基于成像的研究表明,DEK 的纳米级分布如何与乳腺癌模型中的表观遗传标记差异相关。
Sci Rep. 2023 Aug 7;13(1):12749. doi: 10.1038/s41598-023-38685-7.
7
SHFM1 deficiency suppresses esophageal squamous cell carcinomas progression via modulating NF‑κB signaling and enhancing nature killer cell‑mediated tumor surveillance.SHFM1缺陷通过调节NF-κB信号传导和增强自然杀伤细胞介导的肿瘤监视来抑制食管鳞状细胞癌的进展。
Exp Ther Med. 2023 Mar 17;25(5):195. doi: 10.3892/etm.2023.11894. eCollection 2023 May.
8
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis.EZH2-H3K27me3 介导的 KRT14 上调促进三阴性乳腺癌腹膜转移。
Nat Commun. 2022 Nov 29;13(1):7344. doi: 10.1038/s41467-022-35059-x.
9
Racial Disparity in Quadruple Negative Breast Cancer: Aggressive Biology and Potential Therapeutic Targeting and Prevention.三阴性乳腺癌中的种族差异:侵袭性生物学特性及潜在的治疗靶点与预防
Cancers (Basel). 2022 Sep 16;14(18):4484. doi: 10.3390/cancers14184484.
10
Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis.组蛋白修饰在肿瘤转移调控中的突出作用。
Int J Mol Sci. 2021 Mar 9;22(5):2778. doi: 10.3390/ijms22052778.
使用DZNep、丁酸钠和伏立诺他对管腔样和间充质样乳腺癌亚型细胞进行表观遗传修饰
Cancer Genomics Proteomics. 2016 Jul-Aug;13(4):291-303.
4
A novel subtype classification and risk of breast cancer by histone modification profiling.通过组蛋白修饰谱对乳腺癌进行新型亚型分类及风险评估
Breast Cancer Res Treat. 2016 Jun;157(2):267-279. doi: 10.1007/s10549-016-3826-8. Epub 2016 May 13.
5
Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.全球组蛋白修饰谱揭示了四阶段乳腺癌模型中恶性转化过程中的表观基因组动态变化。
Clin Epigenetics. 2016 Mar 31;8:34. doi: 10.1186/s13148-016-0201-x. eCollection 2016.
6
Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information.根据 Ki-67、肿瘤大小和孕激素受体阴性对 Luminal A 和 Luminal B 亚型进行区分,提供预后信息。
Clin Med Insights Oncol. 2014 Sep 11;8:107-11. doi: 10.4137/CMO.S18006. eCollection 2014.
7
Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses' Health Study.护士健康研究中H3K9me3和H3K27me3抑制性组蛋白标记与乳腺癌亚型的关联
Breast Cancer Res Treat. 2014 Oct;147(3):639-51. doi: 10.1007/s10549-014-3089-1. Epub 2014 Sep 16.
8
Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer.RUNX1的表达与三阴性乳腺癌患者的不良预后相关。
PLoS One. 2014 Jun 26;9(6):e100759. doi: 10.1371/journal.pone.0100759. eCollection 2014.
9
Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.比较表观遗传学分析揭示了乳腺癌亚型中致癌途径激活的不同模式。
Hum Mol Genet. 2014 Oct 15;23(20):5378-93. doi: 10.1093/hmg/ddu256. Epub 2014 May 27.
10
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.个体化治疗早期乳腺癌女性:2013 年圣加仑国际早期乳腺癌专家共识初级治疗要点。
Ann Oncol. 2013 Sep;24(9):2206-23. doi: 10.1093/annonc/mdt303. Epub 2013 Aug 4.